Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures

European Journal of Surgical Oncology

Volumn 36, Issue 3, 2010, Pages 309-314

  Saxena, A ^a   Yan, T D ^a   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Iterative; Mortality; Peritonectomy; Toxicity

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ADULT; ARTICLE; CANCER RECURRENCE; CARCINOMATOUS PERITONITIS; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OPERATING ROOM; OVARY CANCER; PATIENT SELECTION; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PERITONECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LAPAROTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEW SOUTH WALES; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 76449093339     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.06.008     Document Type: Article

References (26)

1. Yan T.D., Black D., Savady R., and Sugarbaker P.H. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24 24 (2006) 4011-4019
2. Yan T.D., Black D., Savady R., and Sugarbaker P.H. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14 2 (2007) 484-492
3. Yan T.D., Welch L., Black D., and Sugarbaker P.H. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 18 5 (2007) 827-834
4. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
5. Esquivel J., and Sugarbaker P.H. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg 234 2 (2001) 198-205
6. Kianmanesh R., Scaringi S., Sabate J.M., et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245 4 (2007) 597-603
7. Yan T.D., Bijelic L., and Sugarbaker P.H. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 14 8 (2007) 2289-2299
8. Mohamed F., Chang D., and Sugarbaker P.H. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination. J Surg Oncol 83 1 (2003) 5-12 discussion 12-13
9. Bijelic L., Yan T.D., and Sugarbaker P.H. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 98 4 (2008) 295-299
10. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 16 (2004) 3284-3292
11. Portilla A.G., Sugarbaker P.H., and Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 23 1 (1999) 23-29
12. Stephens A.D., Alderman R., Chang D., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6 8 (1999) 790-796
13. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10 8 (2003) 863-869
14. Kusamura S., Deraco M., Baratti D., et al. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique. J Exp Clin Cancer Res 22 4 Suppl (2003) 207-212
15. Verwaal V.J., van Tinteren H., Ruth S.V., and Zoetmulder F.A. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85 2 (2004) 61-67
16. Hansson J., Graf W., Pahlman L., Nygren P., and Mahteme H. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol (2008)
17. Saxena A., Yan T.D., Chua T.C., et al. Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures. Ann Surg Oncol (2009)
18. ASA. New classification of physical status. Anesthesiology 24 (1963)
19. Jacquet P., and Sugarbaker P.H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82 (1996) 359-374
20. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
21. Yan T.D., Links M., Fransi S., et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy - a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 14 8 (2007) 2270-2280
22. Yan T.D., Yoo D., and Sugarbaker P.H. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 32 9 (2006) 948-953
23. Elias D., Goere D., Blot F., et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 °C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14 6 (2007) 1818-1824
24. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106 5 (2006) 1144-1153
25. Jacquet P., Stephens A.D., Averbach A.M., et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77 12 (1996) 2622-2629
26. McQuellon R.P., Russell G.B., Shen P., Stewart IV J.H., Saunders W., and Levine E.A. Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol 15 1 (2008) 125-133